Pharma & Biotech

The biotech firm Ocugen finds itself at the center of a storm, presenting investors with a perplexing mix of encouraging...

The biotechnology sector witnessed another episode of extreme volatility as Viking Therapeutics shares embarked on a dramatic rollercoaster ride this...

Eli Lilly shares faced downward pressure on Friday following the disclosure of a substantial divestment by one of its most...

A New York bankruptcy judge has authorized the sale of Seelos Therapeutics' remaining assets for $22 million, effectively concluding the...

AIM ImmunoTech continues to experience significant downward pressure on its stock value, even as the company achieves critical milestones in...

Vaxart Inc. finds itself navigating multiple challenges simultaneously as its stock trades at just $0.34 per share. The biotechnology firm...

Renalytix AI has taken a significant step to fortify its financial position through a strategic capital transaction. The company successfully...

Fortress Biotech faces a severe crisis as a law firm initiates a securities fraud investigation, compounding the devastation from a...

The acquisition of 2Seventy Bio by Bristol Myers Squibb in March 2025 for $286 million has effectively rendered the company's...

Medical technology company AngioDynamics is experiencing substantial momentum following the release of its quarterly financial results, which significantly surpassed market...